Armata Pharmaceuticals, Inc. (ARMP)
3.755
0.00 (0.00%)
USD |
NYAM |
Nov 11, 16:00
3.755
0.00 (0.00%)
After-Hours: 20:00
Armata Pharmaceuticals Market Cap : 139.48M for Nov. 11, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 10, 2026 | 139.30M |
| November 09, 2026 | 141.15M |
| November 06, 2026 | 130.38M |
| November 05, 2026 | 111.44M |
| November 04, 2026 | 116.64M |
| November 03, 2026 | 114.78M |
| November 02, 2026 | 105.87M |
| October 30, 2026 | 121.84M |
| October 29, 2026 | 120.72M |
| October 28, 2026 | 122.21M |
| October 27, 2026 | 129.64M |
| October 26, 2026 | 128.15M |
| October 23, 2026 | 135.21M |
| October 22, 2026 | 128.15M |
| October 21, 2026 | 113.67M |
| October 20, 2026 | 118.87M |
| October 19, 2026 | 114.04M |
| October 16, 2026 | 125.18M |
| October 15, 2026 | 114.78M |
| October 14, 2026 | 103.26M |
| October 13, 2026 | 115.15M |
| October 12, 2026 | 134.84M |
| October 09, 2026 | 134.84M |
| October 08, 2026 | 143.38M |
| October 07, 2026 | 141.53M |
| Date | Value |
|---|---|
| October 06, 2026 | 143.01M |
| October 05, 2026 | 135.95M |
| October 02, 2026 | 130.75M |
| October 01, 2026 | 122.95M |
| September 30, 2026 | 136.32M |
| September 29, 2026 | 133.35M |
| September 28, 2026 | 140.41M |
| September 25, 2026 | 138.92M |
| September 24, 2026 | 134.47M |
| September 23, 2026 | 135.21M |
| September 22, 2026 | 156.01M |
| September 21, 2026 | 158.24M |
| September 18, 2026 | 155.27M |
| September 17, 2026 | 152.30M |
| September 16, 2026 | 151.18M |
| September 15, 2026 | 163.44M |
| September 14, 2026 | 206.16M |
| September 11, 2026 | 199.84M |
| September 10, 2026 | 194.27M |
| September 09, 2026 | 200.96M |
| September 08, 2026 | 216.19M |
| September 04, 2026 | 216.93M |
| September 03, 2026 | 205.04M |
| September 02, 2026 | 205.42M |
| September 01, 2026 | 196.13M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Lineage Cell Therapeutics, Inc. | 283.26M |
| Voyager Therapeutics, Inc. | 109.43M |
| Black Diamond Therapeutics, Inc. | 92.20M |
| Invivyd, Inc. | 176.09M |
| Elicio Therapeutics, Inc. | 45.86M |
Market Cap Related Metrics
| PS Ratio | 28.98 |
| PEG Ratio | -0.0005 |
| Price | 3.755 |
| Earnings Yield | -202.0% |
| PEGY Ratio | -0.0005 |